|Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints|
S Koyama, EA Akbay, YY Li, GS Herter-Sprie, KA Buczkowski, ...
Nature communications 7 (1), 1-9, 2016
|STK11/LKB1 Deficiency Promotes Neutrophil Recruitment and Proinflammatory Cytokine Production to Suppress T-cell Activity in the Lung Tumor MicroenvironmentImmunosuppressive …|
S Koyama, EA Akbay, YY Li, AR Aref, F Skoulidis, GS Herter-Sprie, ...
Cancer research 76 (5), 999-1008, 2016
|Mechanisms and therapeutic implications of hypermutation in gliomas|
M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ...
Nature 580 (7804), 517-523, 2020
|Drug repositioning for personalized medicine|
YY Li, SJM Jones
Genome medicine 4 (3), 1-14, 2012
|Genomic Analysis of Metastatic Cutaneous Squamous Cell CarcinomaGenomics of Metastatic Cutaneous Squamous Carcinomas|
YY Li, GJ Hanna, AC Laga, RI Haddad, JH Lorch, PS Hammerman
Clinical cancer research 21 (6), 1447-1456, 2015
|Exome and genome sequencing of nasopharynx cancer identifies NF-κB pathway activating mutations|
YY Li, GTY Chung, VWY Lui, KF To, BBY Ma, C Chow, JK Woo, KY Yip, ...
Nature communications 8 (1), 1-10, 2017
|LKB1 loss links serine metabolism to DNA methylation and tumorigenesis|
F Kottakis, BN Nicolay, A Roumane, R Karnik, H Gu, JM Nagle, ...
Nature 539 (7629), 390-395, 2016
|Evolution of an adenocarcinoma in response to selection by targeted kinase inhibitors|
SJM Jones, J Laskin, YY Li, OL Griffith, J An, M Bilenky, YS Butterfield, ...
Genome biology 11 (8), 1-12, 2010
|Y-box binding protein-1 serine 102 is a downstream target of p90 ribosomal S6 kinase in basal-like breast cancer cells|
AL Stratford, CJ Fry, C Desilets, AH Davies, YY Cho, Y Li, Z Dong, ...
Breast Cancer Research 10 (6), 1-12, 2008
|cisRED: a database system for genome-scale computational discovery of regulatory elements|
G Robertson, M Bilenky, K Lin, A He, W Yuen, M Dagpinar, R Varhol, ...
Nucleic acids research 34 (suppl_1), D68-D73, 2006
|Stemness-related markers in cancer|
W Zhao, Y Li, X Zhang
Cancer translational medicine 3 (3), 87, 2017
|Improving the specificity of high-throughput ortholog prediction|
DL Fulton, YY Li, MR Laird, BGS Horsman, FM Roche, FSL Brinkman
BMC bioinformatics 7 (1), 1-16, 2006
|A computational approach to finding novel targets for existing drugs|
YY Li, J An, SJM Jones
PLoS computational biology 7 (9), e1002139, 2011
|Synergy of radiotherapy and PD-1 blockade in Kras-mutant lung cancer|
GS Herter-Sprie, S Koyama, H Korideck, J Hai, J Deng, YY Li, ...
JCI insight 1 (9), 2016
|Genomic Landscape of Human Papillomavirus–Associated CancersGenomics of HPV-Associated Cancers|
M Rusan, YY Li, PS Hammerman
Clinical cancer research 21 (9), 2009-2019, 2015
|Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers|
J Laskin, S Jones, S Aparicio, S Chia, C Ch'ng, R Deyell, P Eirew, A Fok, ...
Molecular Case Studies 1 (1), a000570, 2015
|Oncogenic Deregulation of EZH2 as an Opportunity for Targeted Therapy in Lung CancerAn Oncogenic Role for EZH2 in Lung Cancer|
H Zhang, J Qi, JM Reyes, L Li, PK Rao, F Li, CY Lin, JA Perry, MA Lawlor, ...
Cancer discovery 6 (9), 1006-1021, 2016
|Molecular Mechanisms of Acquired Resistance to MET Tyrosine Kinase Inhibitors in Patients with MET Exon 14–Mutant NSCLCResistance Mechanisms to MET Tyrosine Kinase Inhibitors|
G Recondo, M Bahcall, LF Spurr, J Che, B Ricciuti, GC Leonardi, YC Lo, ...
Clinical Cancer Research 26 (11), 2615-2625, 2020
|Suppression of myeloid cell arginase activity leads to therapeutic response in a NSCLC mouse model by activating anti-tumor immunity|
JJ Miret, P Kirschmeier, S Koyama, M Zhu, YY Li, Y Naito, M Wu, ...
Journal for immunotherapy of cancer 7 (1), 1-12, 2019
|Impact of DNA Damage Response and Repair (DDR) Gene Mutations on Efficacy of PD-(L) 1 Immune Checkpoint Inhibition in Non–Small Cell Lung CancerDDR Gene Mutations and …|
B Ricciuti, G Recondo, LF Spurr, YY Li, G Lamberti, D Venkatraman, ...
Clinical Cancer Research 26 (15), 4135-4142, 2020